Abstract:OBJECTIVE:To evaluate the effects of hemoglobin (Hb) levels on long-term prognosis in the patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. METHODS:A total of 150 patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention between January 2005 to December 2007 were enrolled. They were divided into 2 groups: Hb < 120 g/L group (n = 21) and Hb ≥ 120 g/L group (n = 129). The mean clinical follow-up period was 3 years (range: 41.4 ± 16.1 months). The differences of major adverse cardiac events (MACE), including death, acute myocardial infarction, stent thrombosis & stent restenosis), were observed between two groups. RESULTS:The parameters of infarction site, infarction relative artery, 2-vessel disease, 3-vessel disease, Killip class ≥ II, drug-eluting stent, TIMI grade 3 flow, hypertension, hyperlipidemia, smoking, obesity, aspirin and clopidogrel use were not different between two groups (all P > 0.05). The rate of diabetes was significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (47.62% vs 18.60%, P = 0.0032). The mean age and symptom-onset-to balloon-time (SOTB) were significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (68.5 ± 9.2 vs 61.2 ± 12.2 years, P < 0.0001; 8.8 ± 10.5 vs 6.3 ± 5.0 h, P < 0.0001). The mean LVEF (left ventricular ejection fraction)(%) and rate of complete revascularization were significantly lower in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (51.25 ± 11.34 vs 58.79 ± 10.38, P < 0.0001; 61.9% vs 86.8%, P = 0.0045). Logistic regression analysis showed that LVEF was an independent predictor of MACE during the follow-up period (P = 0.0140). During a 3-year follow-up, MACE occurred in 16 patients. The incidence of MACE was significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (33.33% vs 6.98%, P = 0.0003); Moreover the all-cause mortality and cardiac mortality were significantly higher in Hb < 120 g/L group than those in Hb ≥ 120 g/L group (28.57% vs 3.10%, P < 0.0001; 23.81% vs 2.33%, P < 0.0001). CONCLUSION:In the patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, hemoglobin level < 120 g/L at baseline is markedly associated with adverse outcomes and an elevated incidence of MACE and mortality during the follow-up period.

Prognostic value of hemoglobin level and CAMI-STEMI score in patients with acute ST segment elevation myocardial infarction after PCI

Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI

Effects of Hemoglobin Levels on Long-Term Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Association of postprocedural neutrophil count and prognosis in ST-elevated myocardial infarction patients after percutaneous coronary intervention

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Association of postprocedural neutrophil count,ST-segment resolution and NT-proBNP in ST elevation myocardial infarction patients after percutaneous coronary intervention

Risk Stratification Algorithm for Clinical Outcomes in Anemic Patients Undergoing Percutaneous Coronary Intervention.

Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis

Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute St-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention

The relationship between serum level of H-FABP before PCI and prognosis in patients with STEMI

Predictive Value of Combination Scores of Leukocyte and Platelet Counts for Mortality in Patients With Acute ST Segment Elevation Myocardial Infarction After PCI Treatment

Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

The Prognostic Value of Serum Homocysteine Level in Patients with Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention

Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty

Anemia As an Independent Predictor of Poor Long-Term Outcomes after Percutaneous Coronary Intervention

Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention

Association between haemoglobin decline and long-term outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention

Serum Glucose Concentrations Independently Predict Early Mortality in Patients with Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

Influence of glycated hemoglobin on long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergone PCI

[The Prognostic Value of Admission Blood Glucose Level in Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention].

[Value of Mean Platelet Volume and Gensini Score on Predicting Short-Term Outcome in Acute ST Segment Elevation Myocardial Infarction Patient Post Emergency Percutaneous Coronary Intervention].